{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:56:03Z","timestamp":1764874563196,"version":"3.46.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Health Commission","award":["2021KY050"],"award-info":[{"award-number":["2021KY050"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Prostate cancer (PCa) remains a leading cause of cancer-related mortality in men, with challenges in diagnosis and treatment due to tumor heterogeneity. This study identifies palmitoylation-related signature genes as potential diagnostic and therapeutic targets. Integrating GEO datasets, six differentially expressed genes (DEGs) linked to palmitoylation were identified. Machine learning algorithms (LASSO, RF, SVM) selected three core genes: TRPM4, LAMB3, and APOE. A diagnostic model based on these genes achieved an AUC of 0.929, demonstrating robust accuracy in distinguishing PCa from normal tissues. Functional analysis revealed roles in lipid metabolism and immune modulation, with ssGSEA highlighting correlations between key genes and immune cell infiltration. Experimental validation showed that LAMB3 overexpression suppressed PCa cell proliferation, migration, and invasion, while knockdown enhanced these processes. Molecular docking identified diethylstilbestrol as a potential therapeutic agent targeting LAMB3 and APOE. These findings emphasize the clinical relevance of palmitoylation-related genes in PCa diagnosis and therapy, offering novel biomarkers and insights for personalized treatment strategies.<\/jats:p>","DOI":"10.1371\/journal.pone.0338407","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:50:32Z","timestamp":1764874232000},"page":"e0338407","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of palmitoylation-related signature genes based on machine learning for prostate cancer"],"prefix":"10.1371","volume":"20","author":[{"given":"Qijun","family":"Wo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiafeng","family":"Shou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YunKai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6782-6496","authenticated-orcid":true,"given":"Liping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"3","key":"pone.0338407.ref001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"pone.0338407.ref002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"pone.0338407.ref003","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/JU.0000000000003452","article-title":"Updates to Advanced Prostate Cancer: AUA\/SUO Guideline (2023)","volume":"209","author":"W Lowrance","year":"2023","journal-title":"J Urol"},{"issue":"13","key":"pone.0338407.ref004","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"FH Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"pone.0338407.ref005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejca.2023.02.018","article-title":"Management of patients with advanced prostate cancer-metastatic and\/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022","volume":"185","author":"S Gillessen","year":"2023","journal-title":"Eur J Cancer"},{"issue":"7","key":"pone.0338407.ref006","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S1470-2045(22)00278-9","article-title":"Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)","volume":"23","author":"N Agarwal","year":"2022","journal-title":"Lancet Oncol"},{"issue":"4","key":"pone.0338407.ref007","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer","volume":"377","author":"K Fizazi","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"pone.0338407.ref008","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-022-01245-y","article-title":"Protein acylation: mechanisms, biological functions and therapeutic targets","volume":"7","author":"S Shang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"pone.0338407.ref009","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41580-024-00700-8","article-title":"Mechanisms and functions of protein S-acylation","volume":"25","author":"F S Mesquita","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"pone.0338407.ref010","doi-asserted-by":"crossref","first-page":"200411","DOI":"10.1098\/rsob.200411","article-title":"Protein S-palmitoylation in immunity","volume":"11","author":"T Das","year":"2021","journal-title":"Open Biol"},{"issue":"10","key":"pone.0338407.ref011","article-title":"Protein palmitoylation and cancer","volume":"19","author":"P Ko","year":"2018","journal-title":"EMBO Reports"},{"issue":"1","key":"pone.0338407.ref012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.13308","article-title":"Protein palmitoylation in cancer: molecular functions and therapeutic potential","volume":"17","author":"B Zhou","year":"2023","journal-title":"Mol Oncol"},{"issue":"2","key":"pone.0338407.ref013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/proteomes6020024","article-title":"Utilizing Optimized Tools to Investigate PTM Crosstalk: Identifying Potential PTM Crosstalk of Acetylated Mitochondrial Proteins","volume":"6","author":"H Horita","year":"2018","journal-title":"Proteomes"},{"issue":"1","key":"pone.0338407.ref014","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-023-01480-x","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"J Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"pone.0338407.ref015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pathol.2020.10.003","article-title":"Molecular pathology of prostate cancer: a practical approach","volume":"53","author":"T Vlajnic","year":"2021","journal-title":"Pathology"},{"issue":"8","key":"pone.0338407.ref016","doi-asserted-by":"crossref","first-page":"166147","DOI":"10.1016\/j.bbadis.2021.166147","article-title":"Homozygous missense mutation in UQCRC2 associated with severe encephalomyopathy, mitochondrial complex III assembly defect and activation of mitochondrial protein quality control","volume":"1867","author":"D Burska","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"pone.0338407.ref017","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbabio.2013.01.009","article-title":"The mechanism of ubihydroquinone oxidation at the Qo-site of the cytochrome bc1 complex","volume":"1827","author":"AR Crofts","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"pone.0338407.ref018","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1042\/BST20160304","article-title":"Structure and function of DHHC protein S-acyltransferases","volume":"45","author":"CD Gottlieb","year":"2017","journal-title":"Biochem Soc Trans"},{"issue":"15","key":"pone.0338407.ref019","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.7150\/ijbs.64046","article-title":"Lipid-induced S-palmitoylation as a Vital Regulator of Cell Signaling and Disease Development","volume":"17","author":"M Qu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"pone.0338407.ref020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.ctm.2015.10.003","article-title":"Local Palmitoylation Cycles and Specialized Membrane Domain Organization","volume":"77","author":"Y Fukata","year":"2016","journal-title":"Curr Top Membr"},{"issue":"22","key":"pone.0338407.ref021","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1074\/jbc.273.22.14037","article-title":"Identification of a palmitic acid-modified form of human Sonic hedgehog","volume":"273","author":"RB Pepinsky","year":"1998","journal-title":"J Biol Chem"},{"issue":"1","key":"pone.0338407.ref022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nchembio.1392","article-title":"Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine","volume":"10","author":"X Gao","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"4","key":"pone.0338407.ref023","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/21541248.2020.1826781","article-title":"Exploring a role for fatty acid synthase in prostate cancer cell migration","volume":"12","author":"M De Piano","year":"2021","journal-title":"Small GTPases"},{"issue":"40","key":"pone.0338407.ref024","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1225-24.2024","article-title":"Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders","volume":"44","author":"J Wlodarczyk","year":"2024","journal-title":"J Neurosci"},{"issue":"1","key":"pone.0338407.ref025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s13287-022-03087-5","article-title":"Propofol enhances stem-like properties of glioma via GABAAR-dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism","volume":"13","author":"X Fan","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"pone.0338407.ref026","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0092-8674(02)00719-5","article-title":"TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization","volume":"109","author":"P Launay","year":"2002","journal-title":"Cell"},{"issue":"4","key":"pone.0338407.ref027","first-page":"779","article-title":"Apolipoprotein E expression in localized prostate cancers","volume":"22","author":"MC Venanzoni","year":"2003","journal-title":"Int J Oncol"},{"issue":"4","key":"pone.0338407.ref028","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3892\/ijo.2013.2057","article-title":"Apolipoprotein E gene polymorphism influences aggressive behavior in prostate cancer cells by deregulating cholesterol homeostasis","volume":"43","author":"GO Ifere","year":"2013","journal-title":"Int J Oncol"},{"issue":"3","key":"pone.0338407.ref029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.02.004","article-title":"Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer","volume":"41","author":"N Bancaro","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"pone.0338407.ref030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12943-016-0567-6","article-title":"Depletion of SAG\/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K\/AKT\/mTOR axis","volume":"15","author":"M Tan","year":"2016","journal-title":"Mol Cancer"},{"issue":"5","key":"pone.0338407.ref031","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1593\/neo.03499","article-title":"Laminin-5 \u03b23A Expression in LNCaP Human Prostate Carcinoma Cells Increases Cell Migration and Tumorigenicity","volume":"6","author":"R Calaluce","year":"2004","journal-title":"Neoplasia"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0338407","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:50:37Z","timestamp":1764874237000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0338407"}},"subtitle":[],"editor":[{"given":"Li","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0338407","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}